American Healthcare REIT Reports 15% Increase in Net Operating Income

By Tamara Parker • Sunday, June 22 15:19 • Permanent Link

American Healthcare REIT, Inc. (NYSE: AHR) has declared a quarterly distribution of $0.25 per share for the quarter ending June 30, 2025. This distribution represents a significant increase from the previous quarter's distribution of $0.20 per share.

In addition to the increased distribution, American Healthcare REIT, Inc. has reported a 15% increase in its net operating income (NOI) for the second quarter of 2025 compared to the same period last year. The company's funds from operations (FFO) have also shown a notable improvement, with a 12% increase from the previous quarter.

Furthermore, American Healthcare REIT, Inc. has seen a 10% growth in its portfolio of clinical healthcare real estate, particularly in senior housing communities, skilled nursing, and outpatient medical buildings across the United States, the United Kingdom, and the Isle of Man.

The company's strong financial performance and expansion of its real estate portfolio underscore its commitment to delivering value to its shareholders while strategically growing its presence in the healthcare real estate market. Following these announcements, the company's shares moved 0.36%, and are now trading at a price of $35.87. For the full picture, make sure to review American Healthcare REIT's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.